CRTC3
Basic information
Region (hg38): 15:90529923-90645345
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CRTC3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 3 | |||||
missense | 28 | 29 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 28 | 2 | 2 |
Variants in CRTC3
This is a list of pathogenic ClinVar variants found in the CRTC3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
15-90530122-G-C | not specified | Uncertain significance (Oct 17, 2023) | ||
15-90530197-G-A | Likely benign (Mar 01, 2023) | |||
15-90540072-A-C | not specified | Uncertain significance (May 26, 2023) | ||
15-90593672-C-T | not specified | Uncertain significance (Apr 27, 2024) | ||
15-90602327-G-A | not specified | Uncertain significance (Jul 09, 2021) | ||
15-90602349-A-G | not specified | Uncertain significance (Jun 17, 2024) | ||
15-90602376-G-A | not specified | Uncertain significance (Apr 19, 2024) | ||
15-90604429-T-C | not specified | Uncertain significance (May 01, 2023) | ||
15-90604438-C-T | not specified | Uncertain significance (Oct 13, 2023) | ||
15-90607453-G-C | not specified | Uncertain significance (Jan 17, 2023) | ||
15-90617932-G-A | Benign (Feb 07, 2018) | |||
15-90625805-G-A | not specified | Uncertain significance (Oct 03, 2023) | ||
15-90625991-C-T | not specified | Uncertain significance (Jan 26, 2023) | ||
15-90629273-C-T | not specified | Uncertain significance (Jul 12, 2022) | ||
15-90629324-C-T | not specified | Uncertain significance (Apr 27, 2022) | ||
15-90629434-G-A | not specified | Uncertain significance (Nov 03, 2023) | ||
15-90629447-C-T | not specified | Uncertain significance (Aug 17, 2022) | ||
15-90629500-A-G | not specified | Uncertain significance (Apr 22, 2024) | ||
15-90629519-A-G | not specified | Uncertain significance (Oct 27, 2022) | ||
15-90638446-A-G | not specified | Uncertain significance (Mar 01, 2023) | ||
15-90638489-A-C | not specified | Uncertain significance (Oct 29, 2021) | ||
15-90638566-C-A | Malignant tumor of prostate | Uncertain significance (-) | ||
15-90638603-C-G | not specified | Uncertain significance (Mar 02, 2023) | ||
15-90638606-C-T | not specified | Uncertain significance (Feb 27, 2024) | ||
15-90638618-A-T | not specified | Uncertain significance (Feb 23, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CRTC3 | protein_coding | protein_coding | ENST00000268184 | 15 | 115421 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.866 | 0.134 | 125737 | 0 | 10 | 125747 | 0.0000398 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.401 | 327 | 348 | 0.940 | 0.0000199 | 3984 |
Missense in Polyphen | 91 | 111.85 | 0.81359 | 1237 | ||
Synonymous | -2.44 | 182 | 145 | 1.26 | 0.00000833 | 1305 |
Loss of Function | 4.35 | 6 | 33.0 | 0.182 | 0.00000182 | 328 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000615 | 0.0000615 |
Ashkenazi Jewish | 0.000298 | 0.000298 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.0000924 | 0.0000924 |
European (Non-Finnish) | 0.0000264 | 0.0000264 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Transcriptional coactivator for CREB1 which activates transcription through both consensus and variant cAMP response element (CRE) sites. Acts as a coactivator, in the SIK/TORC signaling pathway, being active when dephosphorylated and acts independently of CREB1 'Ser-133' phosphorylation. Enhances the interaction of CREB1 with TAF4. Regulates the expression of specific CREB-activated genes such as the steroidogenic gene, StAR. Potent coactivator of PPARGC1A and inducer of mitochondrial biogenesis in muscle cells. Also coactivator for TAX activation of the human T-cell leukemia virus type 1 (HTLV-1) long terminal repeats (LTR). {ECO:0000269|PubMed:14506290, ECO:0000269|PubMed:15454081, ECO:0000269|PubMed:15466468, ECO:0000269|PubMed:16817901, ECO:0000269|PubMed:16980408, ECO:0000269|PubMed:17210223, ECO:0000269|PubMed:17644518}.;
- Pathway
- HTLV-I infection - Homo sapiens (human)
(Consensus)
Recessive Scores
- pRec
- 0.127
Intolerance Scores
- loftool
- 0.399
- rvis_EVS
- -1.24
- rvis_percentile_EVS
- 5.46
Haploinsufficiency Scores
- pHI
- 0.143
- hipred
- Y
- hipred_score
- 0.518
- ghis
- 0.602
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.802
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | High |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Crtc3
- Phenotype
- homeostasis/metabolism phenotype; cellular phenotype; muscle phenotype; growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); liver/biliary system phenotype; skeleton phenotype; limbs/digits/tail phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Gene ontology
- Biological process
- viral process;positive regulation of CREB transcription factor activity;macrophage activation;negative regulation of cAMP-mediated signaling;positive regulation of transcription by RNA polymerase II;negative regulation of lipid catabolic process;protein homotetramerization;energy homeostasis
- Cellular component
- nucleus;nucleoplasm;cytoplasm;cytosol
- Molecular function
- cAMP response element binding protein binding